Sio Gene Therapies, Inc. to File for Dissolution and Declare an Initial Liquidating Distribution of $0.435 Per Share
PARSIPPANY, N.J., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Sio Gene Therapies, Inc. ("Sio") today announced that it expects to file a certificate of dissolution (the "Certificate of Dissolution") with the
Roivant Was Started by Republican Presidential Candidate Vivek Ramaswamy -- WSJ
Roivant Was Started by Republican Presidential Candidate Vivek Ramaswamy -- WSJ
Express News | Roivant in Talks to Sell Stomach Drug to Roche in Deal Valued at More Than $7B, Sources Say -- WSJ
Delisting of Securities of Core Scientific, Inc.; The Very Good Food Company Inc.; HyreCar Inc.; Reeds, Inc.; Sorrento Therapeutics, Inc.; CYREN Ltd.; Lucira Health, Inc.; Qutoutiao Inc.; and Sio Gene Therapies Inc. From The Nasdaq Stock Market
Sio Gene Therapies (NASDAQ:SIOX) Vs. Organigram (NASDAQ:OGI) Head-To-Head Review
Sio Gene Therapies (NASDAQ:SIOX – Get Rating) and Organigram (NASDAQ:OGI – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on
Express News | Sio Gene Therapies 3Q-End Cash, Cash Equivalents $46.1M >SIOX
Express News | Sio Gene Therapies 3Q Loss $4M >SIOX
Express News | Sio Gene Therapies 3Q Loss/Shr 5c >SIOX
Press Release: Sio Gene Therapies Announces Fiscal Third Quarter 2022 Financial Results
Sio Gene Therapies Announces Fiscal Third Quarter 2022 Financial Results -- Three-Month and Nine-Month Losses decline by 84.2% and 73.5%, respectively -- Operating Cash Outflows for the Nine Month
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersCardiovascular Systems (NASDAQ:CSII) shares moved upwards by 48.4% to $19.75 during Thursday's pre-market session. The market value of their outstanding shares is at $827.1 million. The company
Sio Gene Therapies (NASDAQ:SIOX) Stock Price Up 2.3%
Sio Gene Therapies Inc. (NASDAQ:SIOX – Get Rating)'s share price rose 2.3% during mid-day trading on Monday . The stock traded as high as $0.44 and last traded at $0.44. Approximately 440,574 shares
Sio Gene Therapies (NASDAQ:SIOX) Trading 2.3% Higher
Sio Gene Therapies Inc. (NASDAQ:SIOX – Get Rating)'s stock price traded up 2.3% on Monday . The company traded as high as $0.44 and last traded at $0.44. 440,574 shares traded hands during trading, a
Sio Gene Therapies Inc. (NASDAQ:SIOX) Short Interest Update
Sio Gene Therapies Inc. (NASDAQ:SIOX – Get Rating) saw a large growth in short interest in December. As of December 15th, there was short interest totalling 159,700 shares, a growth of 19.8% from th
Why Third Harmonic Bio Shares Are Trading Lower By Over 78%? Here Are 40 Stocks Moving In Thursday's Mid-Day Session
Gainers Crown ElectroKinetics Corp. (NASDAQ:CRKN) jumped 69.6% to $0.2604 after gaining 17% on Wednesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.Core Scientific, Inc. (
Sio Gene Therapies Board Approves Plan of Liquidation, Dissolution; Shares Rise After Hours
05:40 PM EST, 12/14/2022 (MT Newswires) -- Sio Gene Therapies (SIOX) said late Wednesday its board has approved a plan for the dissolution and liquidation of the company, including its subsidiaries. "
Sio Gene Therapies to Dissolve Company, Liquidate Assets
Press Release: Sio Gene Therapies Inc. Announces Board Approval of Plan of Complete Liquidation and Dissolution
Sio Gene Therapies Inc. Announces Board Approval of Plan of Complete Liquidation and Dissolution NEW YORK, Dec. 14, 2022 (GLOBE NEWSWIRE) -- Sio Gene Therapies Inc. (Nasdaq:SIOX) today announced that
On December 14, 2022, The Board Of Directors Of Sio Gene Therapies Unanimously Approved The Dissolution And Liquidation Of The Company Pursuant To A Plan Of Complete Liquidation And Dissolution
On December 14, 2022, the Board of Directors of Sio Gene Therapies Inc. (the "Company") unanimously approved the dissolution and liquidation of the Company pursuant to a plan of complete liquidation a
Why Netcapital Shares Are Trading Lower By Over 33%? Here Are 50 Stocks Moving In Wednesday's Mid-Day Session
Gainers Crown ElectroKinetics Corp. (NASDAQ:CRKN) shares rose 153% to $0.3325 after gaining 14% on Tuesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.Vallon Pharmaceutical
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersSCWorx (NASDAQ:WORX) shares moved upwards by 15.2% to $0.53 during Thursday's after-market session. The company's market cap stands at $6.8 million. Allarity Therapeutics (NASDAQ:ALLR) shares i
No Data